Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 064576/0383 | |
| Pages: | 7 |
| | Recorded: | 08/14/2023 | | |
| Attorney Dkt #: | 34108-00004 |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED AT REEL: 057325 FRAME: 0672. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
|
Total properties:
3
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/19/2022
|
Application #:
|
17001889
|
Filing Dt:
|
08/25/2020
|
|
Publication #:
|
|
Pub Dt:
|
03/04/2021
| | | | |
|
Title:
|
Liposome Formulation of Fluticasone Furoate and Method of Preparation
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17323109
|
Filing Dt:
|
05/18/2021
|
|
Publication #:
|
|
Pub Dt:
|
11/18/2021
| | | | |
|
Title:
|
PHARMACEUTICAL FORMULATION CONTAINING REMDESIVIR AND ITS ACTIVE METABOLITES FOR DRY POWDER INHALATION
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17361471
|
Filing Dt:
|
06/29/2021
|
|
Publication #:
|
|
Pub Dt:
|
12/30/2021
| | | | |
|
Title:
|
PHARMACEUTICAL FORMULATION CONTAINING COMBINATION OF M3 ANTAGONIST-BETA-2 AGONIST AND INHALED CORTICOSTEROIDS
|
|
|
Assignee
|
|
|
|
|
| ONE GATEWAY CENTER |
| SUITE 2600 |
| NEWARK, NEW JERSEY 07102 |
|
|
Correspondence name and address
|
| |
PARKER POE ADAMS & BERNSTEIN LLP
|
| |
1400 K STREET, NW
|
| |
SUITE 1000
|
| |
WASHINGTON, DC 20005
|
Search Results as of:
06/19/2024 01:14 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
